<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">ScientificWorldJournal</journal-id><journal-id journal-id-type="iso-abbrev">ScientificWorldJournal</journal-id><journal-id journal-id-type="publisher-id">TSWJ</journal-id><journal-title-group><journal-title>The Scientific World Journal</journal-title></journal-title-group><issn pub-type="ppub">2356-6140</issn><issn pub-type="epub">1537-744X</issn><publisher><publisher-name>TheScientificWorldJOURNAL</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17370013</article-id><article-id pub-id-type="pmc">5917170</article-id><article-id pub-id-type="publisher-id">597846</article-id><article-id pub-id-type="doi">10.1100/tsw.2006.347</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Significant Delay of Lethal Outcome in Cancer Patients Due to Peroral Administration of Bacillus oligonitrophilus KU-1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Malkov</surname><given-names>Sergey V.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Markelov</surname><given-names>Vladimir V.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Polozov</surname><given-names>Gleb Y.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Barabanschikov</surname><given-names>Boris I.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kozhevnikov</surname><given-names>Alexander Y.</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Trushin</surname><given-names>Maxim V.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>
Kazan State University,
Department of Genetics,
Kremlyovskaya str. 18,
420008 Kazan,
Russia
</aff><aff id="I2">
<sup>2</sup>
Kazan Rehabilitation Medical Health Center "Sanatorium Krutushka",
420008 Kazan,
Russia
</aff><aff id="I3">
<sup>3</sup>
Institute of Biochemistry and Biophysics,
PO Box 30,
420111,
Kazan,
Russia
</aff><author-notes><corresp id="cor1">*Maxim V. Trushin: <email>mtrushin@mail.ru</email></corresp><fn fn-type="other"><p>Academic Editor: Joav Merrick</p></fn></author-notes><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>8</day><month>7</month><year>2006</year></pub-date><volume>6</volume><fpage>2177</fpage><lpage>2187</lpage><history><date date-type="received"><day>16</day><month>4</month><year>2006</year></date><date date-type="rev-recd"><day>13</day><month>6</month><year>2006</year></date><date date-type="accepted"><day>13</day><month>6</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 Sergey V. Malkov et al.</copyright-statement><copyright-year>2006</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Treatment of cancer patients remains a serious medical problem and the development of alternative treatment strategies is therefore of great importance. In this connection, we developed a new bacterial-based, anticancer method. Ten cancer patients (three males, seven females) were involved in this study. Bacterial suspension of stationary phase <italic>Bacillus oligonitrophilus</italic> KU-1 was used as a remedy for peroral administration. In five patients, side effects (sicchasia, slight blood, and intracranial pressure gain) were detected, but all patients showed significant delay of lethal outcome without serious side effects. In conclusion, the suggested method was, in our opinion, a good alternative to conventional chemo- and radiotherapy techniques. In order to evaluate its efficiency for various tumors, a double-blind, placebo-controlled, multicenter study is needed.</p></abstract><kwd-group><kwd>cancer</kwd><kwd>anticancer drug</kwd><kwd>metastasis</kwd><kwd>survival rate</kwd><kwd>Russia</kwd></kwd-group></article-meta></front></article>